Literature DB >> 33387597

Preservative Induced Polysorbate 80 Micelle Aggregation.

Peter H Gilbert1, Zhenhuan Zhang1, Ken K Qian2, David P Allen3, Norman J Wagner4, Yun Liu5.   

Abstract

Small angle neutron scattering (SANS) studies of a model pharmaceutical formulation reveal how formulation stability depends on the compatibility of individual components. Solutions of two common protein formulation excipients, polysorbate 80 (PS80), a nonionic surfactant that prevents aggregation, and m-cresol, an antimicrobial agent for multi-dose injectable formulations, are investigated. The addition of m-cresol to PS80 solutions leads to solution turbidity and irreversibly alters PS80 micelle morphology. This slow preservative-induced destabilization of PS80 micelles progresses over days or even weeks, which highlights the essential role that aggregation kinetics plays in preservative-surfactant interactions. The temperature-dependence of PS80 micelle growth kinetics is quantified by SANS in the presence of m-cresol. Aggregation is a two-step process, where initial formation of small aggregates is followed by a period of monotonic power-law growth, providing evidence for the mechanism. Total aggregate mass stays constant after initial aggregate formation, and addition of a pH-regulating citrate buffer dramatically accelerates aggregation kinetics.
Copyright © 2020 American Pharmacists Association®. All rights reserved.

Entities:  

Keywords:  Micelles; Pharmaceutical formulation; Polysorbate; Preservatives; Small-angle neutron scattering

Year:  2020        PMID: 33387597     DOI: 10.1016/j.xphs.2020.12.030

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  The very small angle neutron scattering instrument at the National Institute of Standards and Technology.

Authors:  John Barker; James Moyer; Steven Kline; Grethe Jensen; Jeremy Cook; Cedric Gagnon; Elizabeth Kelley; Jean Philippe Chabot; Nicholas Maliszewskyj; Chirag Parikh; Wangchun Chen; R P Murphy; Charles Glinka
Journal:  J Appl Crystallogr       Date:  2022-02-27       Impact factor: 3.304

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.